Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: John C. Byrd Sarwish Rafiq |
| Publication date | March 4, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |